Lineweaver Wealth Advisors LLC Invests $592,000 in GE HealthCare Technologies Inc. $GEHC

Key Points

• Lineweaver Wealth Advisors LLC acquired 7,988 shares of GE HealthCare Technologies Inc. for approximately $592,000 in the second quarter.
• GE HealthCare reported a quarterly earnings per share of $1.06, exceeding the estimate of $0.91, and had a revenue of $5 billion for the quarter.
• The company declared a quarterly dividend of $0.035 per share, with a dividend yield of 0.2% and a payout ratio of 2.87%.

Lineweaver Wealth Advisors LLC purchased a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 7,988 shares of the company's stock, valued at approximately $592,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in GEHC. N.E.W. Advisory Services LLC purchased a new stake in GE HealthCare Technologies in the 1st quarter worth approximately $25,000. Bogart Wealth LLC boosted its position in shares of GE HealthCare Technologies by 260.0% during the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company's stock valued at $28,000 after acquiring an additional 247 shares during the last quarter. Stonebridge Financial Group LLC boosted its position in shares of GE HealthCare Technologies by 165.7% during the 1st quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock valued at $29,000 after acquiring an additional 222 shares during the last quarter. Ameriflex Group Inc. bought a new stake in GE HealthCare Technologies in the fourth quarter worth $31,000. Finally, Olde Wealth Management LLC bought a new stake in GE HealthCare Technologies in the first quarter worth $35,000. Hedge funds and other institutional investors own 82.06% of the company's stock.

Analyst Ratings Changes

Several analysts have recently weighed in on GEHC shares. Wall Street Zen downgraded GE HealthCare Technologies from a "buy" rating to a "hold" rating in a research report on Saturday. Morgan Stanley set a $74.00 target price on GE HealthCare Technologies in a research note on Thursday. Citigroup boosted their price target on GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a "buy" rating in a research note on Thursday, July 31st. BTIG Research reaffirmed a "buy" rating on shares of GE HealthCare Technologies in a report on Monday, July 14th. Finally, Zacks Research raised GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a report on Thursday, August 28th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $88.40.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC traded up $0.91 on Friday, reaching $74.91. 6,294,083 shares of the company traded hands, compared to its average volume of 3,137,968. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The company's 50 day moving average is $74.53 and its 200-day moving average is $73.19. The stock has a market capitalization of $34.20 billion, a PE ratio of 15.35, a P/E/G ratio of 2.86 and a beta of 1.13. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, topping the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The firm had revenue of $5 billion for the quarter, compared to the consensus estimate of $4.96 billion. During the same period in the prior year, the business posted $1.00 earnings per share. The business's quarterly revenue was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 25th were given a dividend of $0.035 per share. The ex-dividend date of this dividend was Friday, July 25th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies's payout ratio is 2.87%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.